280748-43-8 Usage
Derivative of pyrrole
A heterocyclic organic compound The compound is based on the pyrrole structure, which is a five-membered ring containing one nitrogen atom and four carbon atoms.
Contains functional groups
Carboxylic acid and aldehyde The molecule has both a carboxylic acid (-COOH) and an aldehyde (-CHO) functional group, which contribute to its reactivity and potential applications in organic synthesis.
Versatile intermediate
Synthesis of biologically active molecules Due to its unique structure and properties, 1H-Pyrrole-2-carboxylic acid, 5-formyl-4-methyl(9CI) is a valuable intermediate for creating various biologically active compounds, such as pharmaceuticals, agrochemicals, and natural products.
Potential applications
New drug or bioactive compound development The compound's structural features make it a promising candidate for the development of new drugs or bioactive compounds with potential therapeutic or agricultural applications.
Check Digit Verification of cas no
The CAS Registry Mumber 280748-43-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,8,0,7,4 and 8 respectively; the second part has 2 digits, 4 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 280748-43:
(8*2)+(7*8)+(6*0)+(5*7)+(4*4)+(3*8)+(2*4)+(1*3)=158
158 % 10 = 8
So 280748-43-8 is a valid CAS Registry Number.
InChI:InChI=1/C7H7NO3/c1-4-2-5(7(10)11)8-6(4)3-9/h2-3,8H,1H3,(H,10,11)
280748-43-8Relevant articles and documents
FORMULATIONS FOR PHARMACEUTICAL AGENTS IONIZABLE AS FREE ACIDS OR FREE BASES
-
, (2008/06/13)
-
Sulfonamide substituted indolinones as inhibitors of DNA dependent protein kinase (DNA-PK)
-
Page 16; 17, (2010/02/10)
The present invention relates generally to the field of radiosensitizing agents which are capable of enhancing radiotherapy by inhibiting DNA-PK (DNA-protein kinase). In particular, it relates to sulfonamide substituted indolinones which inhibit DNA-PK.
Prodrugs of a 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives
-
, (2008/06/13)
The present invention relates to pyrrole substituted 2-indolinone compounds and their pharmaceutically acceptable salts which modulate the activity of protein kinases and therefore are expected to be useful in the prevention and treatment of protein kinase related cellular disorders such as cancer.